IDEAYA Biosciences

IDEAYA’s rare cancer drug shows promise as company lays out Phase III plans
Clinical Trials Arena
Tue, 09/24/24 - 11:54 am
IDEAYA Biosciences
clinical trials
darovasertib
neoadjuvant uveal melanoma
FDA grants fast track designation for IDEAYA’s uveal melanoma therapy
Pharmaceutical Business Review
Tue, 12/6/22 - 10:29 am
IDEAYA Biosciences
darovasertib
uveal melanoma
FDA
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
Sat, 01/16/21 - 11:57 pm
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology